Age, Blasts, Performance Status and Lenalidomide Therapy Influence the Outcome of Myelodysplastic Syndrome With Isolated Del(5q): A Study of 58 South American Patients.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. e1, doi. 10.1016/j.clml.2021.07.026

By:

• Azevedo, R. S.;
• Belli, C.;
• Bassolli, L.;
• Ferri, L.;
• Perusini, M. A.;
• Enrico, A.;
• Pereira, TDM.;
• Junior, WFS;
• Buccheri, V.;
• Pinheiro, R. F.;
• Magalhaes, S. M.;
• SchusterHematology Department, Universidade Federal de MinasGerais (UFMG), Belo Horizonte, Brazil, S.;
• Castelli, J. B.;
• Traina, F.;
• Rocha, V.;
• Velloso, EDRP

Publication type:

Article